Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy.
Hoopfer D, Holloway C, Gabos Z, Alidrisi M, Chafe S, Krause B, Lees A, Mehta N, Tankel K, Strickland F, Hanson J, King C, Ghosh S, Severin D. Hoopfer D, et al. Among authors: chafe s. Clin Breast Cancer. 2015 Jun;15(3):181-90.e1-4. doi: 10.1016/j.clbc.2014.12.006. Epub 2014 Dec 24. Clin Breast Cancer. 2015. PMID: 25619686 Clinical Trial.
Skin-sparing helical tomotherapy vs 3D-conformal radiotherapy for adjuvant breast radiotherapy: in vivo skin dosimetry study.
Capelle L, Warkentin H, Mackenzie M, Joseph K, Gabos Z, Pervez N, Tankel K, Chafe S, Amanie J, Ghosh S, Parliament M, Abdulkarim B. Capelle L, et al. Among authors: chafe s. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e583-90. doi: 10.1016/j.ijrobp.2012.01.086. Epub 2012 May 12. Int J Radiat Oncol Biol Phys. 2012. PMID: 22580119 Clinical Trial.
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
Bruner DW, Hunt D, Michalski JM, Bosch WR, Galvin JM, Amin M, Xiao C, Bahary JP, Patel M, Chafe S, Rodrigues G, Lau H, Duclos M, Baikadi M, Deshmukh S, Sandler HM. Bruner DW, et al. Among authors: chafe s. Cancer. 2015 Jul 15;121(14):2422-30. doi: 10.1002/cncr.29362. Epub 2015 Apr 2. Cancer. 2015. PMID: 25847819 Free PMC article. Clinical Trial.
Cardiac-sparing radiation therapy using positioning breast shell for patients with left-sided breast cancer who are ineligible for breath-hold techniques.
Joseph K, Warkentin H, Ghosh S, Polkosnik LA, Powell K, Brennan M, Warkentin B, Jacobs J, Alkaabi K, Chafe S, Tankel K, Gabos Z, Liu HW, Tai P. Joseph K, et al. Among authors: chafe s. Adv Radiat Oncol. 2017 Aug 26;2(4):532-539. doi: 10.1016/j.adro.2017.08.002. eCollection 2017 Oct-Dec. Adv Radiat Oncol. 2017. PMID: 29204519 Free PMC article.
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial.
Joseph K, Vos LJ, Gabos Z, Pervez N, Chafe S, Tankel K, Warkentin H, Ghosh S, Amanie J, Powell K, Polkosnik LA, Horsman S, MacKenzie M, Sabri S, Parliament MB, Mackey J, Abdulkarim B. Joseph K, et al. Among authors: chafe s. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):30-39. doi: 10.1016/j.clon.2020.07.005. Epub 2020 Jul 22. Clin Oncol (R Coll Radiol). 2021. PMID: 32711920 Free article. Clinical Trial.
Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study.
Joseph K, Zebak S, Alba V, Mah K, Au C, Vos L, Ghosh S, Abraham A, Chafe S, Wiebe E, Liu HW, Chambers C, Gabos Z, Tankel K, Lupichuk S, King K. Joseph K, et al. Among authors: chafe s. Radiother Oncol. 2021 Jan;154:93-100. doi: 10.1016/j.radonc.2020.09.017. Epub 2020 Sep 14. Radiother Oncol. 2021. PMID: 32941956
Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial.
Abraham A, Sanghera KP, Gheisari F, Koumna S, Riauka T, Ghosh S, Warkentin H, Gabos Z, Chafe S, Tankel K, Huang F, Sabri S, Paterson DI, Abdulkarim B, Joseph K. Abraham A, et al. Among authors: chafe s. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):125-134. doi: 10.1016/j.ijrobp.2022.01.020. Epub 2022 Jan 25. Int J Radiat Oncol Biol Phys. 2022. PMID: 35085715 Clinical Trial.
Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
Chafe S, Moughan J, McCormick B, Wong J, Pass H, Rabinovitch R, Arthur DW, Petersen I, White J, Vicini FA. Chafe S, et al. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):854-9. doi: 10.1016/j.ijrobp.2013.04.005. Epub 2013 May 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23726000 Clinical Trial.
Regional Nodal Irradiation in Early-Stage Breast Cancer.
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JA, Chen BE, Levine MN; MA.20 Study Investigators. Whelan TJ, et al. Among authors: chafe s. N Engl J Med. 2015 Jul 23;373(4):307-16. doi: 10.1056/NEJMoa1415340. N Engl J Med. 2015. PMID: 26200977 Free PMC article. Clinical Trial.
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera FE, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham WA, Chua BH, Gu CS, Levine MN, Olivotto IA; RAPID Trial Investigators. Whelan TJ, et al. Among authors: chafe s. Lancet. 2019 Dec 14;394(10215):2165-2172. doi: 10.1016/S0140-6736(19)32515-2. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813635 Clinical Trial.
55 results